Rachel Albright, DPM
Foot & Ankle Surgery · Darien, CTNPI 1790172930
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Synthes GmbH at 54.4% of the total. Among foot & ankle surgery clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $468.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$8K
- Endo Pharmaceuticals Inc.$6K
- Smith+Nephew$245
- Organogenesis Inc.$117
- Amgen$105
- Medline Industries LP$104
- plus $202 from 3 others
What the payments were for
- Consulting fees$5,88042%
- Speaking & faculty fees$2,00014%
- Travel & lodging$4,79834%
- Food & beverage$1,37210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 15 | $7,644 |
| Endo Pharmaceuticals Inc. | 7 | $5,633 |
| Smith+Nephew | 2 | $245 |
| Organogenesis Inc. | 1 | $117 |
| Amgen | 1 | $105 |
| Medline Industries LP | 1 | $104 |
| GRT US Holding, Inc. | 1 | $97 |
| Nuo Therapeutics | 1 | $67 |
| Medtronic | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,050 in reported general payments places this provider in the 90th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 77 | $2,058 |
| Gabapentin | 36 | $318 |
| Methylprednisolone | 30 | $204 |
| Ammonium Lactate | 14 | $138 |
| Terbinafine Hcl | 20 | $131 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $119 |
| Mupirocin | 14 | $106 |
| Ciprofloxacin Hcl | 12 | $56 |
| Meloxicam | 18 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Darien
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Paulina PiekarskaNorwalk$13K
- Allen FerrucciHamden$13K
- Andrew LitchfieldRocky Hill$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.